A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen
Author(s) -
Brenna C. Simons,
Philip R. Spradling,
Dana Bruden,
Carolyn Zanis,
Samantha Case,
Tammy L. Choromanski,
Minjun C. Apodaca,
Hazel D. Brogdon,
Gaelen K. Dwyer,
Mary Snowball,
Susan Negus,
Michael G. Bruce,
Chihiro Morishima,
Cindy Knall,
Brian J. McMahon
Publication year - 2016
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiw142
Subject(s) - hepatitis b virus , immunology , medicine , hepatitis b , virology , vaccination , antibody , antigen , hepatitis b vaccine , immunization , immunity , serology , hepadnaviridae , virus , immune system , hbsag
Long-lasting protection resulting from hepatitis B vaccine, despite loss of antibody against hepatitis B virus (HBV) surface antigen (anti-HBs), is undetermined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom